These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 1693044)

  • 1. Cerebrospinal fluid studies in the Rett syndrome: biogenic amines and beta-endorphins.
    Budden SS; Myer EC; Butler IJ
    Brain Dev; 1990; 12(1):81-4. PubMed ID: 1693044
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cerebrospinal fluid concentrations of folate, biogenic amines and pterins in Rett syndrome: treatment with folinic acid.
    Ormazabal A; Artuch R; Vilaseca MA; Aracil A; Pineda M
    Neuropediatrics; 2005 Dec; 36(6):380-5. PubMed ID: 16429378
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CSF beta-endorphins in childhood neuropsychiatric disorders.
    Gillberg C; Terenius L; Hagberg B; Witt-Engerström I; Eriksson I
    Brain Dev; 1990; 12(1):88-92. PubMed ID: 2344033
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CSF and urine biogenic amine metabolites in Rett syndrome.
    Lekman A; Witt-Engerström I; Holmberg B; Percy A; Svennerholm L; Hagberg B
    Clin Genet; 1990 Mar; 37(3):173-8. PubMed ID: 1691058
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reduction of biogenic amine levels in the Rett syndrome.
    Zoghbi HY; Percy AK; Glaze DG; Butler IJ; Riccardi VM
    N Engl J Med; 1985 Oct; 313(15):921-4. PubMed ID: 2412119
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Rett syndrome and CSF lactic acid patterns.
    Matsuishi T; Urabe F; Komori H; Yamashita Y; Naito E; Kuroda Y; Horikawa M; Ohtaki E
    Brain Dev; 1992 Jan; 14(1):68-70. PubMed ID: 1590531
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Possible hyperendorphinergic pathophysiology of the Rett syndrome.
    Brase DA; Myer EC; Dewey WL
    Life Sci; 1989; 45(5):359-66. PubMed ID: 2475733
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Naloxone (Narcan) treatment in depression: clinical observations and effects on CSF endorphins and monoamine metabolites.
    Terenius L; Wahlström A; Agren H
    Psychopharmacology (Berl); 1977 Aug; 54(1):31-3. PubMed ID: 410058
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relationships between CSF levels of endorphins and monoamine metabolites in chronic pain patients.
    Almay BG; Johansson F; von Knorring L; Sedvall G; Terenius L
    Psychopharmacology (Berl); 1980 Feb; 67(2):139-42. PubMed ID: 6154301
    [No Abstract]   [Full Text] [Related]  

  • 10. Cerebrospinal fluid beta-endorphin and cortisol study in Rett syndrome.
    Echenne B; Bressot N; Bassir M; Daures JP; Rabinowitz A
    J Child Neurol; 1991 Jul; 6(3):257-62. PubMed ID: 1875029
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neurochemistry of the Rett syndrome.
    Percy AK
    Brain Dev; 1992 May; 14 Suppl():S57-62. PubMed ID: 1626636
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biogenic amine metabolites in cerebrospinal fluid of patients with affective disorders.
    Vestergaard P; Sørensen T; Hoppe E; Rafaelsen OJ; Yates CM; Nicolaou N
    Acta Psychiatr Scand; 1978 Jul; 58(1):88-96. PubMed ID: 696380
    [No Abstract]   [Full Text] [Related]  

  • 13. Abnormal carbohydrate metabolism in cerebrospinal fluid in Rett syndrome.
    Matsuishi T; Urabe F; Percy AK; Komori H; Yamashita Y; Schultz RS; Ohtani Y; Kuriya N; Kato H
    J Child Neurol; 1994 Jan; 9(1):26-30. PubMed ID: 8151077
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Elevated CSF beta-endorphin immunoreactivity in Rett's syndrome: report of 158 cases and comparison with leukemic children.
    Myer EC; Tripathi HL; Brase DA; Dewey WL
    Neurology; 1992 Feb; 42(2):357-60. PubMed ID: 1736165
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of age on cerebrospinal fluid levels of metabolites of biopterin and biogenic amines.
    Komori H; Matsuishi T; Yamada S; Ueda N; Yamashita Y; Kato H
    Acta Paediatr; 1999 Dec; 88(12):1344-7. PubMed ID: 10626519
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Correlations between height of subject and concentrations of monoamine metabolites in cerebrospinal fluid from psychotic men and women.
    Wode-Helgodt B; Sedvall G
    Commun Psychopharmacol; 1978; 2(2):177-83. PubMed ID: 668302
    [No Abstract]   [Full Text] [Related]  

  • 17. Cerebrospinal fluid biogenic amines and biopterin in Rett syndrome.
    Zoghbi HY; Milstien S; Butler IJ; Smith EO; Kaufman S; Glaze DG; Percy AK
    Ann Neurol; 1989 Jan; 25(1):56-60. PubMed ID: 2913929
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cerebrospinal fluid values for monoamine metabolites, gamma-aminobutyric acid, and other amino compounds in Rett syndrome.
    Perry TL; Dunn HG; Ho HH; Crichton JU
    J Pediatr; 1988 Feb; 112(2):234-8. PubMed ID: 2448442
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biogenic amine metabolism in Tourette syndrome.
    Butler IJ; Koslow SH; Seifert WE; Caprioli RM; Singer HS
    Ann Neurol; 1979 Jul; 6(1):37-9. PubMed ID: 292354
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of electromagnetic fields on the levels of biogenic amine metabolites, quinolinic acid, and beta-endorphin in the cerebrospinal fluid of dairy cows.
    Burchard JF; Nguyen DH; Richard L; Young SN; Heyes MP; Block E
    Neurochem Res; 1998 Dec; 23(12):1527-31. PubMed ID: 9821157
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.